Free Trial Information
BioCentury | May 4, 2018
Financial News

Scholar Rock files for IPO

...who is a co-founder and director at Scholar Rock; Fidelity; Polaris Partners; Arch Venture Partners; Artal...
Read More
BioCentury | Apr 28, 2018
Financial News

Scholar Rock files for IPO

...who is a co-founder and director at Scholar Rock; Fidelity; Polaris Partners; Arch Venture Partners; Artal...
Read More
BioCentury | Aug 17, 2006
Financial News

TolerRx raises $35.6 million

...Research Foundation joined existing investors Skyline Ventures; Bear Stearns Health Innoventures; Sprout Group; Rho Ventures; Artal...
Read More
BioCentury | Apr 4, 2005
Finance

Ebb & Flow

...the round were NIF Ventures; Skyline Ventures; HealthCare Ventures; Rho Ventures; Vertex Management; Sprout Group; Artal...
Read More
BioCentury | Mar 30, 2005
Top Story

TolerRx raises $31M

...Other investors included NIF Ventures; Skyline Ventures; HealthCare Ventures; Rho Ventures; Vertex Management; Sprout Group; Artal...
Read More
BioCentury | Feb 23, 2004
Company News

Large Scale Biology management update

Large Scale Biology Corp. (LSBC), Vacaville, Calif. Business: Genomics, Proteomics, Biomanufacturing Transitioning: Kevin Ryan to president of LSBC's Eclipse Diagnostics Inc. subsidiary, while remaining president and CEO of LSBC; John Rakitan to SVP and general...
Read More
BioCentury | Sep 1, 2003
Finance

Ebb & Flow

...include HealthCare Ventures (31.2%); Skyline Venture Partners (16.8%); Sprout Group (10.8%); Rho Capital Management (9%); Artal...
Read More
BioCentury | Apr 21, 2003
Company News

Large Scale Biology management update

Large Scale Biology Corp. (LSBC), Vacaville, Calif. Business: Genomics, Proteomics, Cancer Hired: Kevin Ryan, a director, as president and CEO Departed: Robert Erwin as CEO, while remaining chairman Resigned: John Fowler as president, while remaining...
Read More
BioCentury | Jan 6, 2003
Finance

Ebb & Flow

...Ventures led the TolerRx deal, which included HealthCare Ventures; Rho Ventures; Vertex Management; Sprout Group; Artal...
Read More
BioCentury | Jan 3, 2003
Top Story

TolerRx raises $35M; signs DNA deal

...led by Skyline Ventures. Other investors included HealthCare Ventures; Rho Ventures; Vertex Management; Sprout Group; Artal...
Read More
Items per page:
1 - 10 of 12
BioCentury | May 4, 2018
Financial News

Scholar Rock files for IPO

...who is a co-founder and director at Scholar Rock; Fidelity; Polaris Partners; Arch Venture Partners; Artal...
Read More
BioCentury | Apr 28, 2018
Financial News

Scholar Rock files for IPO

...who is a co-founder and director at Scholar Rock; Fidelity; Polaris Partners; Arch Venture Partners; Artal...
Read More
BioCentury | Aug 17, 2006
Financial News

TolerRx raises $35.6 million

...Research Foundation joined existing investors Skyline Ventures; Bear Stearns Health Innoventures; Sprout Group; Rho Ventures; Artal...
Read More
BioCentury | Apr 4, 2005
Finance

Ebb & Flow

...the round were NIF Ventures; Skyline Ventures; HealthCare Ventures; Rho Ventures; Vertex Management; Sprout Group; Artal...
Read More
BioCentury | Mar 30, 2005
Top Story

TolerRx raises $31M

...Other investors included NIF Ventures; Skyline Ventures; HealthCare Ventures; Rho Ventures; Vertex Management; Sprout Group; Artal...
Read More
BioCentury | Feb 23, 2004
Company News

Large Scale Biology management update

Large Scale Biology Corp. (LSBC), Vacaville, Calif. Business: Genomics, Proteomics, Biomanufacturing Transitioning: Kevin Ryan to president of LSBC's Eclipse Diagnostics Inc. subsidiary, while remaining president and CEO of LSBC; John Rakitan to SVP and general...
Read More
BioCentury | Sep 1, 2003
Finance

Ebb & Flow

...include HealthCare Ventures (31.2%); Skyline Venture Partners (16.8%); Sprout Group (10.8%); Rho Capital Management (9%); Artal...
Read More
BioCentury | Apr 21, 2003
Company News

Large Scale Biology management update

Large Scale Biology Corp. (LSBC), Vacaville, Calif. Business: Genomics, Proteomics, Cancer Hired: Kevin Ryan, a director, as president and CEO Departed: Robert Erwin as CEO, while remaining chairman Resigned: John Fowler as president, while remaining...
Read More
BioCentury | Jan 6, 2003
Finance

Ebb & Flow

...Ventures led the TolerRx deal, which included HealthCare Ventures; Rho Ventures; Vertex Management; Sprout Group; Artal...
Read More
BioCentury | Jan 3, 2003
Top Story

TolerRx raises $35M; signs DNA deal

...led by Skyline Ventures. Other investors included HealthCare Ventures; Rho Ventures; Vertex Management; Sprout Group; Artal...
Read More
Items per page:
1 - 10 of 12